|
EP1012180B1
(en)
|
1997-08-11 |
2004-12-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptide analogues
|
|
DE69829381T2
(de)
|
1997-08-11 |
2006-04-13 |
Boehringer Ingelheim (Canada) Ltd., Laval |
Hepatitis c inhibitor peptide
|
|
AR022061A1
(es)
|
1998-08-10 |
2002-09-04 |
Boehringer Ingelheim Ca Ltd |
Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos.
|
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
|
EP1162196A4
(en)
|
1999-12-27 |
2003-04-16 |
Japan Tobacco Inc |
COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
|
|
JP4748911B2
(ja)
|
2000-04-05 |
2011-08-17 |
シェーリング コーポレイション |
Ｎ−環状ｐ２部分を含むｃ型肝炎ウイルスの大環状ｎｓ３‐セリンプロテアーゼ阻害剤
|
|
NZ521456A
(en)
|
2000-04-19 |
2004-07-30 |
Schering Corp |
Macrocyclic NS3-Serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
|
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
MXPA03000627A
(es)
|
2000-07-21 |
2004-07-30 |
Schering Corp |
Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c.
|
|
WO2002008187A1
(en)
|
2000-07-21 |
2002-01-31 |
Schering Corporation |
Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
|
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
|
AR034127A1
(es)
|
2000-07-21 |
2004-02-04 |
Schering Corp |
Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento
|
|
CA2429359A1
(en)
|
2000-11-20 |
2002-08-08 |
Bristol-Myers Squibb Company |
Hepatitis c tripeptide inhibitors
|
|
HUP0303436A2
(hu)
|
2000-12-12 |
2004-01-28 |
Schering Corp. |
Diaril-peptidek mint a hepatitis C vírus NS3-szerin proteáz inhibitorai, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
|
|
AR035543A1
(es)
*
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
WO2003004458A1
(en)
*
|
2001-07-03 |
2003-01-16 |
Biovitrum Ab |
New compounds
|
|
WO2003007945A1
(en)
|
2001-07-20 |
2003-01-30 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
US20030134853A1
(en)
|
2001-09-26 |
2003-07-17 |
Priestley Eldon Scott |
Compounds useful for treating hepatitis C virus
|
|
US6867185B2
(en)
|
2001-12-20 |
2005-03-15 |
Bristol-Myers Squibb Company |
Inhibitors of hepatitis C virus
|
|
AU2003207625B2
(en)
|
2002-01-23 |
2006-09-07 |
Schering Corporation |
Proline compounds as NS3-serine protease inhibitors for use in treatment of hepatites C virus infection
|
|
CA2369711A1
(en)
|
2002-01-30 |
2003-07-30 |
Boehringer Ingelheim (Canada) Ltd. |
Macrocyclic peptides active against the hepatitis c virus
|
|
CA2369970A1
(en)
|
2002-02-01 |
2003-08-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor tri-peptides
|
|
CA2370396A1
(en)
|
2002-02-01 |
2003-08-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor tri-peptides
|
|
GB0209884D0
(en)
|
2002-04-30 |
2002-06-05 |
Ares Trading Sa |
Proteins
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
WO2004032827A2
(en)
|
2002-05-20 |
2004-04-22 |
Bristol-Myers Squibb Company |
Hepatitis c virus inhibitors
|
|
US6878722B2
(en)
|
2002-05-20 |
2005-04-12 |
Bristol-Myers Squibb Company |
Substituted cycloalkyl P1′ hepatitis C virus inhibitors
|
|
EP1511751B1
(en)
|
2002-06-04 |
2008-03-19 |
Neogenesis Pharmaceuticals, Inc. |
Pyrazolo[1,5-a]pyrimidine compounds as antiviral agents
|
|
US20040138109A1
(en)
|
2002-09-30 |
2004-07-15 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Potent inhibitor of HCV serine protease
|
|
US20050075279A1
(en)
|
2002-10-25 |
2005-04-07 |
Boehringer Ingelheim International Gmbh |
Macrocyclic peptides active against the hepatitis C virus
|
|
US20050159345A1
(en)
|
2002-10-29 |
2005-07-21 |
Boehringer Ingelheim International Gmbh |
Composition for the treatment of infection by Flaviviridae viruses
|
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
US7098231B2
(en)
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
AU2004211637C1
(en)
|
2003-02-07 |
2010-08-19 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic hepatitis C serine protease inhibitors
|
|
JP4682140B2
(ja)
|
2003-03-05 |
2011-05-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃ型肝炎インヒビターペプチド類縁体
|
|
EP1601685A1
(en)
|
2003-03-05 |
2005-12-07 |
Boehringer Ingelheim International GmbH |
Hepatitis c inhibiting compounds
|
|
GB0307891D0
(en)
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
EP1629000B1
(en)
|
2003-04-16 |
2009-02-18 |
Bristol-Myers Squibb Company |
Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
|
|
SI1615613T1
(sl)
|
2003-04-18 |
2010-03-31 |
Enanta Pharm Inc |
Kinoksalinilni makrociklični inhibitorji serinske proteaze hepatitisa C
|
|
HRP20080014T3
(en)
|
2003-05-21 |
2008-02-29 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
|
WO2004113365A2
(en)
|
2003-06-05 |
2004-12-29 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c serine protease tri-peptide inhibitors
|
|
US7125845B2
(en)
|
2003-07-03 |
2006-10-24 |
Enanta Pharmaceuticals, Inc. |
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
|
|
CA2534649A1
(en)
|
2003-08-01 |
2005-02-10 |
Genelabs Technologies, Inc. |
Bicyclic imidazol derivatives against flaviviridae
|
|
WO2005014543A1
(ja)
|
2003-08-06 |
2005-02-17 |
Japan Tobacco Inc. |
縮合環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用
|
|
WO2005021584A2
(en)
|
2003-08-26 |
2005-03-10 |
Schering Corporation |
Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
|
|
US7112601B2
(en)
*
|
2003-09-11 |
2006-09-26 |
Bristol-Myers Squibb Company |
Cycloalkyl heterocycles for treating hepatitis C virus
|
|
RS20060197A
(sr)
|
2003-09-22 |
2008-09-29 |
Boehringer Ingelheim International Gmbh., |
Makrociklični peptidi koji su aktivni protiv hepatitisa c virusa
|
|
KR20060085248A
(ko)
|
2003-09-26 |
2006-07-26 |
쉐링 코포레이션 |
Ｃ형 간염 바이러스 ｎｓ3 세린 프로테아제의마크로사이클릭 억제제
|
|
TW201245229A
(en)
|
2003-10-14 |
2012-11-16 |
Hoffmann La Roche |
Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
|
|
US7132504B2
(en)
|
2003-11-12 |
2006-11-07 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
EP1688420A4
(en)
|
2003-11-19 |
2008-10-22 |
Japan Tobacco Inc |
5-5 LOW-CONDENSED HETEROCYCLIC COMPOUND AND THEIR USE AS HCV POLYMERASE INHIBITOR
|
|
US7309708B2
(en)
|
2003-11-20 |
2007-12-18 |
Birstol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7135462B2
(en)
|
2003-11-20 |
2006-11-14 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
JP2007532479A
(ja)
|
2003-11-20 |
2007-11-15 |
シェーリング コーポレイション |
Ｃ型肝炎ウイルスｎｓ３プロテアーゼの脱ペプチド化インヒビター
|
|
CA2549167A1
(en)
|
2003-12-11 |
2005-06-30 |
Schering Corporation |
Inhibitors of hepatitis c virus ns3/ns4a serine protease
|
|
ATE495185T1
(de)
|
2004-01-21 |
2011-01-15 |
Boehringer Ingelheim Int |
Makrocyclische peptide mit wirkung gegen das hepatitis-c-virus
|
|
UY28758A1
(es)
|
2004-02-20 |
2005-09-30 |
Boehringer Ingelheim Int |
Inhibidores de polimerasa viral
|
|
CN1946690A
(zh)
|
2004-02-27 |
2007-04-11 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的含环丁烯二酮基团化合物
|
|
US7205330B2
(en)
|
2004-02-27 |
2007-04-17 |
Schering Corporation |
Inhibitors of hepatitis C virus NS3 protease
|
|
MY145081A
(en)
|
2004-02-27 |
2011-12-15 |
Schering Corp |
Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
|
|
ES2328589T3
(es)
|
2004-02-27 |
2009-11-16 |
Schering Corporation |
Compuestos de la prolina 3,4(ciclopentil) fusionados como inhibidores de la proteasa serina ns3 del virus de la hepatitis c.
|
|
US7192957B2
(en)
|
2004-02-27 |
2007-03-20 |
Schering Corporation |
Compounds as inhibitors of hepatitis C virus NS3 serine protease
|
|
AU2005219824B2
(en)
|
2004-02-27 |
2007-11-29 |
Merck Sharp & Dohme Corp. |
Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus
|
|
DE602005023224D1
(de)
|
2004-02-27 |
2010-10-07 |
Schering Corp |
Neuartige Verbindungen als Hemmer von Hepatitis C-Virus NS3-Serinprotease
|
|
AR049635A1
(es)
|
2004-05-06 |
2006-08-23 |
Schering Corp |
(1r,2s,5s)-n-((1s)-3-amino-1-(ciclobutilmetil)-2,3-dioxopropil)-3-((2s)-2-((((1,1-dimetiletil)amino)carbonil)amino)-3,3-dimetil-1-oxobutil)-6,6-dimetil-3-azabiciclo(3.1.0)hexan-2-carboxamida como inhibidor de la ns3/ns4a serina proteasa del virus de la hepatitis c
|
|
CN1984922A
(zh)
|
2004-05-20 |
2007-06-20 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的取代脯氨酸
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
WO2006000085A1
(en)
|
2004-06-28 |
2006-01-05 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor peptide analogs
|
|
UY29017A1
(es)
|
2004-07-16 |
2006-02-24 |
Boehringer Ingelheim Int |
Inhibidores de polimerasa viral
|
|
JP4914355B2
(ja)
|
2004-07-20 |
2012-04-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃ型肝炎インヒビターペプチド類似体
|
|
UY29016A1
(es)
|
2004-07-20 |
2006-02-24 |
Boehringer Ingelheim Int |
Analogos de dipeptidos inhibidores de la hepatitis c
|
|
US7816348B2
(en)
*
|
2006-02-03 |
2010-10-19 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|